ArisGlobal Achieves Strong Global Growth and Continued Innovation in First Half 2025
Expanding Impact of LifeSphere® NavaX™ Across the Industry, 27 Go-Lives, ...
Expanding Impact of LifeSphere® NavaX™ Across the Industry, 27 Go-Lives, ...
ArisGlobal is thrilled to announce their participation at the World Drug Safety Congress Americas, September 01 – 02, 2020. Along with a large drug manufacturer, they will be co-presenting a session titled “Enhancing Operations: Enabling Digital Transformation with Next-Gen Technology”.
ArisGlobal, is thrilled to be a Corporate Support Sponsor and to attend the SCOPE Summit for Clinical Ops Executives at the Hyatt Regency Orlando in Orlando, Florida from February 18 – 21, 2020, presented by the Cambridge Healthtech Institute.
ArisGlobal to Present “Automating Health Authority Correspondence and Commitments on a Unified Regulatory Platform” on Tuesday, February 11, 2020, at DIA Regulatory Submissions, Information and Document Management Forum (RSIDM).
A multinational tobacco products manufacturing company recently selected ArisGlobal’s LifeSphere® MultiVigilance 10, industry’s first and only automated adverse event platform for their global safety vigilance needs.
Linical a market-leading, midsized, global contract research organization (CRO) adopted ArisGlobal’s LifeSphere MultiVigilance as their primary global safety management system, industry’s first and only automated adverse event platform.
ArisGlobal announced it has made a number of new key leadership hires, with the express purpose of preparing for accelerated growth in North America, Europe, and Asia, and new product launches in 2020, according to President and CEO Sankesh Abbhi.
Leading Indian CRO enters partnership with ArisGlobal to enhance its ...
Multi-tenant cloud solution acts as front end to any safety database and integrates with mobile-based applications to automate and standardize the case intake process for reports received from the field, reducing costs for greater ROI
Life science organizations can be utilizing the platform’s full clinical ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved